Meiact

Cefditoren pivoxil, the active ingredient in Meiact, is a third‑generation cephalosporin presented as an oral tablet for oral use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Meiact as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Cefditoren pivoxil is indicated for infections caused by susceptible bacteria in the respiratory and skin‑soft tissue tracts.

Acute bacterial sinusitis: effective treatment of sinus infection caused by susceptible organisms. Acute exacerbations of chronic bronchitis: helps resolve bacterial flare‑ups. Community‑acquired pneumonia: used to eradicate the causative pathogens. Skin and soft‑tissue infections: treats cellulitis, abscesses and wound infections. Pharyngitis / tonsillitis: resolves bacterial throat infections.

Cefditoren pivoxil may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain - Headache - Dyspepsia - Rash

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis - Anaphylaxis or severe hypersensitivity reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Elevated liver enzymes or hepatitis - Neutropenia or agranulocytosis - Hemolytic anemia

Before prescribing cefditoren pivoxil, clinicians should consider several safety aspects. - Renal impairment: assess renal function and adjust dose if necessary. - Hepatic dysfunction: monitor liver enzymes during therapy. - History of penicillin allergy: evaluate risk of cross‑reactivity. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concomitant anticoagulants: monitor coagulation parameters for possible interaction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Cefditoren pivoxil can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Probenecid: may increase cefditoren plasma concentrations. - Antacids containing aluminum or magnesium: reduce oral absorption of cefditoren. - Warfarin: may potentiate anticoagulant effect and increase INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Macrolide antibiotics: additive gastrointestinal side effects. - Loop diuretics: may increase risk of electrolyte disturbances.